BASi Announces Extension of Mortgage Maturity
WEST LAFAYETTE, Ind. -- November 4, 2013
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it has
negotiated a twelve month extension, until October 31, 2014, on the maturity
of its $5,255,000 mortgage that was originally scheduled to mature on October
"This extension enhances our flexibility as we continue to explore
alternatives for this debt, including a sale/leaseback transaction on our
building in West Lafayette or a refinancing," said President, CEO and CFO
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract research
services and monitoring instruments to the world's leading drug development
companies and medical research organizations. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking a new drug to market. Visit www.BASinc.com for more
This release contains forward-looking statements that are subject to risks and
uncertainties including, but not limited to, risks and uncertainties related
to changes in the market and demand for our products and services, the
development, marketing and sales of products and services, changes in
technology, industry standards and regulatory standards, and various market
and operating risks detailed in the company's filings with the Securities and
Bioanalytical Systems, Inc.
President, CEO and CFO
Press spacebar to pause and continue. Press esc to stop.